Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
Real-time Estimate Quote. Real-time Estimate CHI-X - 11/26 11:30:00 am
7785 GBX   -0.19%
05:16pNEWS HIGHLIGHTS : Top Company News of the Day
DJ
03:31pASTRAZENECA : says working with regulators on best approach to lower dose regimen
RE
03:16pNEWS HIGHLIGHTS : Top Company News of the Day
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

AstraZeneca : COVID-19 Vaccine Trial From AstraZeneca, Oxford Can Resume In U.S. - WSJ

10/23/2020 | 02:19pm EST

Oct 23 (Reuters) -

* COVID-19 VACCINE TRIAL FROM ASTRAZENECA, OXFORD CAN RESUME IN U.S. - WSJ

* FEDERAL HEALTH REGULATORS HAVE DECIDED TO ALLOW RESUMPTION OF U.S. STUDIES OF COVID-19 VACCINE CANDIDATE FROM ASTRAZENECA, UNIVERSITY OF OXFORD - WSJ Source text: https://on.wsj.com/31SzeR9 Further company coverage:


© Reuters 2020
All news about ASTRAZENECA PLC
05:16pNEWS HIGHLIGHTS : Top Company News of the Day
DJ
03:31pASTRAZENECA : says working with regulators on best approach to lower dose regime..
RE
03:16pNEWS HIGHLIGHTS : Top Company News of the Day
DJ
02:11pRussia's Sputnik V developers call on AstraZeneca to try combining vaccines
RE
01:16pNEWS HIGHLIGHTS : Top Company News of the Day
DJ
11:16aNEWS HIGHLIGHTS : Top Company News of the Day
DJ
10:58aANALYSIS : Questions over AstraZeneca's COVID-19 vaccine data risk delaying appr..
RE
10:06aWhy the Oxford Astrazeneca Vaccine Is Now a Global Gamechanger
AQ
09:16aNEWS HIGHLIGHTS : Top Company News of the Day
DJ
09:02a'WE'RE READY' : Schiphol airport gears up for chilled vaccine cargos
RE
More news
Financials (USD)
Sales 2020 26 512 M - -
Net income 2020 2 998 M - -
Net Debt 2020 13 181 M - -
P/E ratio 2020 46,6x
Yield 2020 2,72%
Capitalization 136 B 136 B -
EV / Sales 2020 5,62x
EV / Sales 2021 4,89x
Nbr of Employees 70 600
Free-Float 95,7%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 121,48 $
Last Close Price 103,46 $
Spread / Highest target 50,3%
Spread / Average Target 17,4%
Spread / Lowest Target -36,2%
EPS Revisions
Managers
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Pam P. Cheng Executive VP-Operations & Information Technology
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC1.85%137 013
JOHNSON & JOHNSON-1.50%378 244
ROCHE HOLDING AG-4.41%282 585
PFIZER INC.-1.59%203 048
NOVARTIS AG-11.88%202 620
MERCK & CO., INC.-11.97%202 555